Short-term outcomes of capecitabine plus oxaliplatin versus S-1 plus oxaliplatin as adjuvant chemotherapies for advanced gastric cancer after laparoscopic gastrectomy and D2 resection: A prospective, multicenter randomized, controlled clinical trial

被引：0
|
作者：
Yan, Y. [1 ]
Lu, L. [1 ]
Wang, X. [1 ]
Wang, D. [1 ]
Huang, Q. [2 ]
Zhao, Q. [3 ]
Liu, T. [1 ]
Fu, W. [1 ]
机构：
[1] Tianjin Med Univ, Tianjin, Peoples R China
[2] Shanxi Prov Canc Hosp, Taiyuan, Shanxi, Peoples R China
[3] Hebei Med Univ 4 Hosp, Shijiazhuang, Hebei, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.04.149
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-67
引用
收藏
页码：S111 / S111
页数：1
相关论文
共 50 条
  • [1] Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy
    Nakamura, Yoshiaki
    Yamanaka, Takeharu
    Chin, Keisho
    Cho, Haruhiko
    Katai, Hitoshi
    Terashima, Masanori
    Misawa, Kazunari
    Hirao, Motohiro
    Yoshida, Kazuhiro
    Oki, Eiji
    Sasako, Mitsuru
    Emi, Yasunori
    Bando, Hideaki
    Kawashima, Yoshiyuki
    Fukunaga, Tetsu
    Gotoh, Masahiro
    Ishibashi, Takako
    Shitara, Kohei
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (02) : 465 - 472
  • [2] Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy
    Yoshiaki Nakamura
    Takeharu Yamanaka
    Keisho Chin
    Haruhiko Cho
    Hitoshi Katai
    Masanori Terashima
    Kazunari Misawa
    Motohiro Hirao
    Kazuhiro Yoshida
    Eiji Oki
    Mitsuru Sasako
    Yasunori Emi
    Hideaki Bando
    Yoshiyuki Kawashima
    Tetsu Fukunaga
    Masahiro Gotoh
    Takako Ishibashi
    Kohei Shitara
    Annals of Surgical Oncology, 2019, 26 : 465 - 472
  • [3] Capecitabine Plus Oxaliplatin Versus Capecitabine Plus Oxaliplatin with Concurrent Radiation Therapy in the Treatment of Gastric Cancer after D2 Gastrectomy
    Xie, C.
    Chen, D.
    Jin, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S28 - S29
  • [4] Capecitabine plus oxaliplatin versus capecitabine plus oxaliplatin with concurrent radiotherapy in the treatment of gastric cancer after D2 gastrectomy.
    Xie, Congying
    Jin, Xiance
    Chen, Didi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Comparison of S-1 plus oxaliplatin (SOX) and capecitabine plus oxaliplatin (XELOX) as adjuvant chemotherapies for stage II and III gastric cancer after D2 resection: A single-center retrospective study
    Jiang, Zhichao
    Sun, Yongkun
    Zhang, Wen
    Cui, Chengxu
    Yang, Lin
    Zhou, Aiping
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 (03) : 180 - 186
  • [6] A retrospective study of adjuvant albumin-bound paclitaxel plus S-1 after D2 gastrectomy versus oxaliplatin plus S-1 in gastric cancer
    Li, Ning
    Wu, Hui
    Xu, Xin
    Wei, Qinming
    Ding, Yongfeng
    Liu, Shan
    Wu, Jinqiong
    Zheng, Yulong
    Xu, Nong
    Gao, Yuan
    Jiang, Haiping
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [7] Three-year outcomes of two phase II studies of adjuvant chemotherapy with S-1 plus oxaliplatin or capecitabine plus oxaliplatin in patients with stage III gastric cancer after D2 gastrectomy
    Nakamura, Yoshiaki
    Yamanaka, Takeharu
    Chin, Keisho
    Cho, Haruhiko
    Katai, Hitoshi
    Terashima, Masanori
    Ito, Seiji
    Hirao, Motohiro
    Yoshida, Kazuhiro
    Oki, Eiji
    Sasako, Mitsuru
    Emi, Yasunori
    Bando, Hideaki
    Kawashima, Yoshiyuki
    Fukunaga, Tetsu
    Gotoh, Masahiro
    Ishibashi, Takako
    Shitara, Kohei
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [8] Clinicians preference of adjuvant S-1 versus capecitabine plus oxaliplatin after curative gastrectomy
    Hwang, In Gyu
    Park, Se Hoon
    Kang, Jung Hun
    Kim, Young Saing
    Oh, Sung Yong
    Won, Young-Woong
    Lee, Soonil
    Ji, Jun Ho
    Chi, Kyong-Choun
    Lee, Ha Yeon
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy
    Cho, Jang Ho
    Lim, Jae Yun
    Cho, Jae Yong
    PLOS ONE, 2017, 12 (10):
  • [10] Adjuvant nab-paclitaxel plus S-1 versus oxaliplatin plus capecitabine after curative D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase 3 open-label, randomized controlled trial
    Yu Pengfei
    Du, Yian
    Xu, Zhiyuan
    Yang, Litao
    Ying, Jieer
    Chen, Ping
    Wei, Yunhai
    Wu, Yingjie
    Yan, Zhilong
    Xu, Hongtao
    Zhang, Xiaojing
    Li, Yong
    Zheng, Zhichao
    Chen, Zhiheng
    Cheng, Xiangdong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 386 - 386
12345